NewsRoom Articles - Page 113 of 218

MondayJun 27, 2022 1:30 am

Silo Pharma Inc. (SILO) Takes Aim at Alzheimer’s Disease

In October 2021, Silo Pharma (OTCQB: SILO) entered into a sponsored research agreement (“SRA”) with Columbia University to investigate and advance psychedelic therapeutics for Alzheimer's Disease (“AD”). SRA’s grant Silo access to world-class research facilities to sponsor potential life-changing research while offering Silo licensing opportunities for groundbreaking psychedelic remedies. Columbia University Irving Medical Center (“CUIMC”), an “internationally recognized leader” in research and therapeutic development, partnered with Silo to study psychedelics’ ability to improve, slow, or even reverse functional decline and memory loss associated with Alzheimer's disease. Associate Professor of Clinical Neurobiology, Dr. Christine Ann Denny, helming the research for Silo,…

FridayJun 24, 2022 1:59 pm

New Research Says Immune Cell Proliferation May Be Associated with Multiple Sclerosis Onset

New research has discovered that there may be a link between higher levels of immune cells in the blood and multiple sclerosis . For the research, scientists studied the genetic data of a large group of individuals with European ancestry. They found that a specific immune cell known as natural killer cells was associated with a 24% rise in the risk of developing multiple sclerosis. The researchers, whose findings were reported in “Frontiers in Immunology,” state that understanding the link between natural killer cells and multiple sclerosis could help them develop potential therapies for this illness. Multiple sclerosis develops when…

FridayJun 24, 2022 12:00 pm

Hope of Herd Immunity Dwindles Alongside Federal COVID-19 Budget and Supplies; Aditxt Inc. (NASDAQ: ADTX) and AditxtScore(TM) Could Create Map to COVID-19 Immune Responses

Two years after a vaccine was made available for COVID-19, fewer than 70% of Americans have been vaccinated The AditxtScore(TM) can provide the necessary answers to individualized immune response questions and direct on the best course of treatment for the individual – not the herd No additional funding for COVID-19 relief has been approved by Congress, requiring the Biden Administration to reallocate funds to prepare for the fall months and uptick in virus counts The reallocation of funds for further vaccine development has reduced the amount spent on testing efforts causing concern for epidemiologists due to the lack of variant…

ThursdayJun 23, 2022 10:02 am

Uncertainty Causes Patients with Systemic Autoimmune Conditions to Be Depressed

Data from new research has revealed a clear link between systemic autoimmune rheumatic disorders and mental health concerns such as anxiety, and depression. These mental health outcomes are due to illness-related uncertainty. Dr. Zachary Wallace from Massachusetts General Hospital states that while current medications have proven to be effective in addressing the symptoms of rheumatoid conditions, patients often struggle to come to terms with their diagnosis and how it will impact the rest of their lives. Katie Willard Virant, a psychotherapist, adds that to live with a chronic illness is to live with a heightened sense of uncertainty. According to…

WednesdayJun 22, 2022 3:24 pm

Study Suggests Healthcare Workers Don’t Know Enough About Childhood Brain Tumors

A recent survey presented at the recent International Symposium on Pediatric Neuro-Oncology (ISPNO) suggests that healthcare workers have some knowledge gaps when it comes to central nervous system (CNS) tumors in children. For their study, researchers from St. Jude Children’s Research Hospital distributed questionnaires to healthcare providers as part of a cross-sectional survey. Their objective was to evaluate the knowledge these providers had about tumors in children. The questionnaire’s main focus was on the symptoms and imaging indications of central nervous system tumors. Every healthcare provider was invited to fill out the questionnaire before and after an educational seminar, which…

TuesdayJun 21, 2022 9:58 am

New Study Finds Dose Tapering May Heighten Risk of Opioid Overdoses

New research from the Center for Healthcare Policy and Research at UC Davis has found that dose-reduction programs meant to taper patients off opioids and reduce opioid overdoses can increase the risk of mental health risks and patient overdose in the long term. In the study findings, which were published in “JAMA Network Open,” the researchers noted that patients on higher doses of opioid therapy experienced remarkably higher rates of mental-health crises and overdose in the second year after their doses were tapered down by at least 15%. Opioid tapering is meant to steadily wean patients off opioids over a…

TuesdayJun 21, 2022 9:00 am

Odyssey Health, Inc. (ODYY) Interview Addresses Company’s Focus on Development of Drug and Device Technologies to Treat Unmet Medical Needs

Odyssey Group International Inc. is a Nevada based medical company developing a variety of drug and technology assets to treat unmet clinical needs Odyssey CEO Michael Redmond recently appeared on Bloomberg TV’s The RedChip Money Report(R) to discuss the development pipeline for three of the company’s four products and pending clinical testing Odyssey’s assets include treatments for patients who may have undiagnosed heart disease, patients choking on some type of obstruction lodged in their throats, patients dealing with a rare neurodegenerative disorder and patients needing treatment for brain concussion injuries The drug-device combination for treating concussions is advancing in a…

FridayJun 17, 2022 11:37 am

Diseases Suppressed by COVID-19 Restrictions Reemerge in Peculiar Ways

The coronavirus pandemic besieged the world for more than two years, forcing countries around the globe to shut down and quarantine in a bid to halt the spread of the virus. Nearly two and a half years after authorities in Wuhan, China, reported the outbreak of a novel coronavirus, the world is starting to emerge from the pandemic. Governments have been lifting lockdown restrictions and mask mandates for the past couple of months, allowing their residents to finally get out of their homes after months and months of isolation. However, the coronavirus pandemic and the subsequent lockdowns seem to have…

ThursdayJun 16, 2022 3:33 pm

New Breakthrough Suggests a Liver Can Survive for Days Before Transplantation

Liver transplants have saved thousands of lives around the world. The procedure itself can be extremely challenging and resource intensive though, as it often requires specialized machinery and the input of dozens of high-level specialists. Furthermore, donor livers are scarce, and doctors often have a narrow window of eight to twelve hours before they have to transplant a liver after extraction. This means that liver transplants often require precise coordination to ensure the donor liver is still viable by the time it reaches the recipient. Researchers from Wyss Zurich and the University Hospital Zurich have discovered a way to keep…

WednesdayJun 15, 2022 12:16 pm

Symptoms of Brain Tumors To Watch For

Data shows that at least 700,000 Americans are currently living with brain tumors. However, experts say the average person has less than a 1% chance of developing brain cancer or spinal cord tumor, with the main risk factors being radiation exposure, family history, seizures, and exposure to viruses, allergens and infections. Knowing the warning signs of brain cancer will allow you to obtain the treatment you need as soon as possible and increase your chances of surviving the disease. Below are some symptoms to watch for. Vision problems Issues such as blurry eyesight or poor peripheral vision may point to…